Paola Neri

1.6k total citations · 1 hit paper
24 papers, 1.1k citations indexed

About

Paola Neri is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Paola Neri has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Hematology and 7 papers in Immunology. Recurrent topics in Paola Neri's work include Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Paola Neri is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Paola Neri collaborates with scholars based in United States, Italy and Canada. Paola Neri's co-authors include Kenneth C. Anderson, Nikhil C. Munshi, Pierfrancesco Tassone, Teru Hideshima, Dharminder Chauhan, Tanyel Kiziltepe, Ellen Weisberg, Yu‐Tzu Tai, Peter Atadja and Laurence Catley and has published in prestigious journals such as Blood, Cancer Cell and Cancer Research.

In The Last Decade

Paola Neri

23 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients

2023 131 citations Mirco Friedrich, Paola Neri et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paola Neri United States	12	686	438	390	208	182	24	1.1k
Kristine Misund Norway	20	669 1.0×	205 0.5×	276 0.7×	124 0.6×	69 0.4×	50	986
Walden Ai United States	22	1.3k 1.9×	426 1.0×	152 0.4×	442 2.1×	72 0.4×	27	1.9k
Ewa Marcinkowska Poland	24	746 1.1×	155 0.4×	201 0.5×	184 0.9×	483 2.7×	71	1.3k
Benito Casanova Spain	13	307 0.4×	129 0.3×	70 0.2×	133 0.6×	95 0.5×	16	751
Hong Zheng China	19	621 0.9×	245 0.6×	181 0.5×	233 1.1×	32 0.2×	47	1.1k
Catherine Fady United States	8	378 0.6×	175 0.4×	164 0.4×	123 0.6×	46 0.3×	10	656
Lynn Ueno United States	9	630 0.9×	221 0.5×	52 0.1×	126 0.6×	75 0.4×	13	910
Josephine A. Carew United States	16	626 0.9×	132 0.3×	237 0.6×	245 1.2×	31 0.2×	32	1.1k
Zi Wang China	17	585 0.9×	205 0.5×	59 0.2×	103 0.5×	91 0.5×	64	968

Countries citing papers authored by Paola Neri

Since Specialization

Citations

This map shows the geographic impact of Paola Neri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paola Neri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paola Neri more than expected).

Fields of papers citing papers by Paola Neri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paola Neri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paola Neri. The network helps show where Paola Neri may publish in the future.

Co-authorship network of co-authors of Paola Neri

This figure shows the co-authorship network connecting the top 25 collaborators of Paola Neri. A scholar is included among the top collaborators of Paola Neri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paola Neri. Paola Neri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neri, Paola, Noémie Leblay, Holly Lee, et al.. (2024). Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins. Nature Reviews Clinical Oncology. 21(8). 590–609. 9 indexed citations

Friedrich, Mirco, Paola Neri, Simon Steiger, et al.. (2023). The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. Cancer Cell. 41(4). 711–725.e6. 131 indexed citations breakdown →

Jiménez‐Zepeda, Víctor H., Peter Duggan, Paola Neri, Jason Tay, & Nizar J. Bahlis. (2017). Absolute Lymphocyte Count and Immunoparesis: Impact on Clinical Outcomes for Non-transplant Eligible MM Patients. Clinical Lymphoma Myeloma & Leukemia. 17(1). e114–e115. 1 indexed citations

Duggan, Peter, et al.. (2017). Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet?. Bone Marrow Transplantation. 52(6). 915–917. 10 indexed citations

Tassone, Pierfrancesco, Maria Teresa Di Martino, Antonella Pietragalla, et al.. (2009). Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo. Cancer Biology & Therapy. 8(7). 648–653. 74 indexed citations

Burger, Renate, Steven Le Gouill, Yu-Tzu Tai, et al.. (2009). Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cellsin vitroandin vivo. Molecular Cancer Therapeutics. 8(1). 26–35. 47 indexed citations

Shammas, Masood A., Hemanta Koley, Robert C. Bertheau, et al.. (2008). Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo. Leukemia. 22(7). 1410–1418. 88 indexed citations

Neri, Paola, Pierosandro Tagliaferri, Maria Teresa Di Martino, et al.. (2008). In vivo anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor. British Journal of Haematology. 143(4). 520–531. 56 indexed citations

Yasui, Hiroshi, Teru Hideshima, Hiroshi Ikeda, et al.. (2007). Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of β-catenin/TCF pathway. Leukemia. 21(3). 535–540. 21 indexed citations

10.

Shammas, Masood A., Paola Neri, Hemanta Koley, et al.. (2006). Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications. Blood. 108(8). 2804–2810. 147 indexed citations

11.

Catley, Laurence, Ellen Weisberg, Tanyel Kiziltepe, et al.. (2006). Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells. Blood. 108(10). 3441–3449. 268 indexed citations

12.

Yasui, Hiroshi, Teru Hideshima, Paola Neri, et al.. (2005). R-Etodolac and a Novel Indole-Pyran Structural Analog, SDX-308, Induce Cytotoxicity and Overcome Drug Resistance in Multiple Myeloma.. Blood. 106(11). 1580–1580. 1 indexed citations

13.

Neri, Paola, Pierfrancesco Tassone, Masood A. Shammas, et al.. (2005). In Vivo Anti-Tumor Activity of Atiprimod on SCID Models of Multiple Myeloma.. Blood. 106(11). 249–249. 1 indexed citations

14.

Tassone, Pierfrancesco, Paola Neri, Jeffery L. Kutok, et al.. (2005). A SCID-hu in vivo model of human Waldenstrom macroglobulinemia. Blood. 106(4). 1341–1345. 29 indexed citations

15.

Chauhan, Dharminder, Yan Chang, Deli He, et al.. (2005). Expression and Modulation of Carbohydrate-Binding Protein Galectin-3 in Multiple Myeloma Cells by Combined Treatment with GCS-100 and Dexamethasone.. Blood. 106(11). 4447–4447. 1 indexed citations

16.

Santos, Daniel, Allen W. Ho, Olivier Tournilhac, et al.. (2005). Establishment of a Waldenstrom’s Macroglobulinemia Cell Line (BCWM.1) with Productive In Vivo Engraftment in SCID-hu Mice.. Blood. 106(11). 979–979. 6 indexed citations

17.

Tassone, Pierfrancesco, Victor S. Goldmacher, Paola Neri, et al.. (2004). Cytotoxic activity of the maytansinoid immunoconjugate B-B4–DM1 against CD138+ multiple myeloma cells. Blood. 104(12). 3688–3696. 94 indexed citations

18.

Shammas, Masood A., Hemanta Koley, Ramesh B. Batchu, et al.. (2004). Specific Killing of Multiple Myeloma Cancer Cells by Epigallocatechin-3-Gallate Extracted from Green Tea.. Blood. 104(11). 2461–2461. 3 indexed citations

19.

Chauhan, Dharminder, Guilan Li, Teru Hideshima, et al.. (2004). Targeting Mitochondrial Factor Smac/DIABLO as Therapy for Multiple Myeloma (MM).. Blood. 104(11). 764–764. 5 indexed citations

20.

Graziano, Alessandro Di, Maria Leggio, Laura Mandolesi, et al.. (2002). Learning power of single behavioral units in acquisition of a complex spatial behavior: An observational learning study in cerebellar-lesioned rats.. Behavioral Neuroscience. 116(1). 116–125. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact